Dr. Larry Lynd received his bachelor of science in pharmacy in 1986 from the University of Saskatchewan and his PhD in the department of health care and epidemiology at the University of British Columbia in 2002. He then completed a two-year post-doctoral fellowship in health economics with Bernie O’Brien at McMaster University. Currently, Lynd is a professor in the faculty of pharmaceutical sciences and is the director of the collaboration for outcomes research and evaluation at UBC also a scientist at the Centre for Clinical Epidemiology and Evaluation, a scientist at the Centre for Health Evaluation and Outcomes Sciences, scholar at the Peter Wall Institute of Advanced Studies and associate of UBC’s school of population and public health. He was also a Michael Smith Foundation for Health Research scholar and a Canadian Institutes of Health Research new investigator.

Lynd has made significant service contributions, serving on several committees, including chair of Health Canada’s special advisory committee on non-prescription drugs, special advisory committee to the respiratory and allergy therapies division of Health Canada, B.C. Ministry of Health Services’ expensive drugs for rare diseases committee and the B.C. PharmaNet Data stewardship committee. Lynd’s primary areas of scholarly interest are state-of-the-art outcomes research and epidemiologic studies. One of his primary research objectives is to be involved in research that will ultimately translate into improved patient outcomes or be integrated into the decision-making process.